Boya Chen
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
-
- Cardiac Fibrosis and Remodeling
Papers in
-
- Genomics and Chromatin Dynamics 2
- Epigenetics and DNA Methylation 2
- Histone Deacetylase Inhibitors Research 2
- Photosynthetic Processes and Mechanisms 2
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Jie Du (6 shared papers)Yulin Li (4 shared papers)Congcong Zhang (3 shared papers)Luxin Liu (2 shared papers)Xi A (1 shared paper)C Y Wang (1 shared paper)Bokang Qiao (2 shared papers)Wayne Bond Lau (1 shared paper)
- Journals
- Expert Opinion on Drug Safety (1 paper)The Journal of Immunology (1 paper)Molecular Therapy (1 paper)Advanced Materials (1 paper)Photosynthesis Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Boya Chen
21 papers receiving 1.1k citations
Boya Chen's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 208
- Cardiology and Cardiovascular Medicine 203
- Molecular Biology 576
- Immunology 129
- Family Practice 9
Countries citing papers authored by Boya Chen
This map shows the geographic impact of Boya Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boya Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boya Chen more than expected).
Fields of papers citing papers by Boya Chen
This network shows the impact of papers produced by Boya Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boya Chen. The network helps show where Boya Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Boya Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage-Derived mir-155-Containing Exosomes Suppress Fibroblast Proliferation and Promote Fibroblast Inflammation during Cardiac Injury Hit paper breakdown → | 2017 | 346 |
| 2 | 2019 | 251 | |
| 3 | 2022 | 104 | |
| 4 | 2018 | 92 | |
| 5 | 2018 | 43 | |
| 6 | 2018 | 38 | |
| 7 | 2017 | 35 | |
| 8 | 2017 | 29 | |
| 9 | 2022 | 29 | |
| 10 | 2024 | 19 | |
| 11 | 2024 | 16 | |
| 12 | 2013 | 13 | |
| 13 | 2016 | 12 | |
| 14 | 2025 | 11 | |
| 15 | 2025 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2016 | 4 | |
| 19 | 2023 | 2 | |
| 20 | 2023 | 1 |
About Boya Chen
Boya Chen is a scholar working on Molecular Biology, Biomaterials, Cardiology and Cardiovascular Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (2 papers), Epigenetics and DNA Methylation (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Photosynthetic Processes and Mechanisms (2 papers), Peptidase Inhibition and Analysis (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Aortic Disease and Treatment Approaches (2 papers). The work is most often cited by research in Cancer Research (208 citations), Cardiology and Cardiovascular Medicine (203 citations), Molecular Biology (576 citations), Immunology (129 citations) and Family Practice (9 citations). Boya Chen has collaborated with scholars based in China and United States. Frequent co-authors include Jie Du, Yulin Li, Congcong Zhang, Luxin Liu, Xi A, C Y Wang, Bokang Qiao, Wayne Bond Lau, Yan Liu and Xinying Yang. Their work appears in journals such as Expert Opinion on Drug Safety, The Journal of Immunology, Molecular Therapy, Advanced Materials and Photosynthesis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.